產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-BMAL1抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-BMAL1抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-BMAL1
Cat. Number:
Anti-BMAL1抗體KL-3750R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Component of the Anti-BMAL1抗體circadian clock oscillator which includes the CRY proteins, CLOCK or NPAS2, ARNTL or ARNTL2, CSNK1D and/or CSNK1E, TIMELESS and the PER proteins. Efficient DNA binding requires dimerization with another bHLH protein. Heterodimerization with CLOCK is required for E-box-dependent transactivation, for CLOCK nuclear translocation and degradation, and, for phosphorylation of both CLOCK and ARNTL. Interaction with PER and CRY proteins requires translocation to the nucleus. Interaction of the CLOCK-ARNTL heterodimer with PER or CRY inhibits transcription activation. Interacts with HSP90; with AHR in vitro, but not in vivo.
Also known as:
ARNT like protein Anti-BMAL1抗體1 brain and muscle; ARNTL; Aryl hydrocarbon receptor nuclear translocator like; Aryl hydrocarbon receptor nuclear translocator like protein 1; Aryl hydrocarbon receptor nuclear translocator-like protein 1; Basic helix loop helix PAS orphan MOP3; bHLH PAS protein JAP3; bHLHe5; BMAL 1; BMAL1c; Brain and muscle ARNT like 1; cycle; JAP 3; JAP3; Member of PAS protein 3; Member of PAS superfamily 3; MOP3; PAS domain-containing protein 3; PASD 3; PASD3; TIC.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human,Anti-BMAL1抗體 Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human BMAL1.
●
Predicted Molecular Weight: 69kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-BMAL1抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-BMAL1抗體dilutions must be determined by the end user.
kl140Bo01 尿激酶型纖溶酶原激活因子(uPA)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Ga01 尿激酶型纖溶酶原激活因子(uPA)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Hu01 尿激酶型纖溶酶原激活因子(uPA)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Mu01 尿激酶型纖溶酶原激活因子(uPA)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Po01 尿激酶型纖溶酶原激活因子(uPA)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Ra01 尿激酶型纖溶酶原激活因子(uPA)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Rb51 尿激酶型纖溶酶原激活因子(uPA)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl141Bo01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl141Hu01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl141Mu01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl141Ra01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl141Si01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl142Hu01 細(xì)胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl142Mu01 細(xì)胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl142Rb51 細(xì)胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl143Ca01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Eq01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
